DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,009,949 | -1.3% | 12,132 | -4.5% | 0.89% | +8.8% |
| Q2 2023 | $3,048,480 | -5.1% | 12,702 | -0.3% | 0.82% | -8.4% |
| Q1 2023 | $3,211,240 | -8.0% | 12,741 | -3.1% | 0.89% | -9.4% |
| Q4 2022 | $3,488,945 | +1.4% | 13,145 | -1.4% | 0.98% | -8.4% |
| Q3 2022 | $3,442,000 | +3.1% | 13,325 | +1.2% | 1.07% | +5.4% |
| Q2 2022 | $3,338,000 | -10.8% | 13,167 | +3.2% | 1.02% | +4.5% |
| Q1 2022 | $3,742,000 | -7.4% | 12,760 | +3.9% | 0.97% | -1.0% |
| Q4 2021 | $4,041,000 | +11.1% | 12,281 | +2.8% | 0.98% | +3.1% |
| Q3 2021 | $3,636,000 | +19.1% | 11,944 | +5.0% | 0.95% | +14.9% |
| Q2 2021 | $3,053,000 | +23.7% | 11,376 | +3.7% | 0.83% | -0.1% |
| Q1 2021 | $2,469,000 | +14.1% | 10,969 | +12.7% | 0.83% | +3.7% |
| Q4 2020 | $2,163,000 | +3.7% | 9,736 | +0.5% | 0.80% | -6.1% |
| Q3 2020 | $2,085,000 | +32.0% | 9,683 | +8.4% | 0.85% | +19.6% |
| Q2 2020 | $1,579,000 | +28.6% | 8,929 | +0.6% | 0.71% | +7.2% |
| Q1 2020 | $1,228,000 | -7.2% | 8,875 | +3.0% | 0.66% | +20.3% |
| Q4 2019 | $1,323,000 | +11.7% | 8,620 | +5.1% | 0.55% | +6.6% |
| Q3 2019 | $1,184,000 | +6.0% | 8,201 | +4.9% | 0.52% | +4.0% |
| Q2 2019 | $1,117,000 | +8.8% | 7,815 | +0.5% | 0.50% | +6.6% |
| Q1 2019 | $1,027,000 | +30.8% | 7,778 | +2.2% | 0.47% | +18.8% |
| Q4 2018 | $785,000 | – | 7,614 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |